Consistently Maintaining Global Standard Laboratory Quality, Prodia Maintains CAP and ISO 15189:2022 Accreditation

Jakarta, June 25, 2026 - PT Prodia Widyahusada Tbk (Stock Code: PRDA) continues to maintain the quality standards of its diagnostic services through various accreditation achievements. One of them is the success of maintaining accreditation from the College of American Pathologists (CAP) since 2012 until now, making Prodia the first and only laboratory in Indonesia to be accredited by CAP. As the golden standard of global laboratories, CAP accreditation proves Prodia's consistency in producing accurate, reliable, and internationally recognized laboratory tests. Through CAP accreditation, Prodia's test results can be used in healthcare services abroad without the need for re-examination, because each examination process has met strict quality control standards.

Furthermore, Prodia maintains its ISO 15189:2022 accreditation with the code LM-001, making it the first laboratory in Indonesia to be accredited with the quality management system and medical laboratory competency standards. This demonstrates Prodia's commitment to maintaining service quality and implementing laboratory practices that meet the best standards in its field.

With over 53 years of experience, Prodia remains committed to implementing Good Laboratory Practices and providing comprehensive, accurate, and reliable diagnostic services. All of these achievements are part of Prodia's ongoing efforts to provide an excellent customer journey and support improvements in the health of the Indonesian public.

#Prodia #AkreditasiCAP #ISO15189 #StandarGlobal #MutuLaboratorium #PromotingHealthcareServicesForAll

Source: www.prodia.co.id